Akebia Therapeutics (AKBA) Tops Q4 EPS by 14c
Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.52), $0.14 better than the analyst estimate of ($0.66).
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.
Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.52), $0.14 better than the analyst estimate of ($0.66).
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.